Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Safety”

268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 268 results

Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Looking for participantsNCT06753916
What this trial is testing

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

Who this might be right for
Corneal Transplant Failure
Massachusetts Eye and Ear Infirmary 96
Large-scale testing (Phase 3)UnknownNCT04017338
What this trial is testing

Transplantation Using Hepatitis C Positive Donors, A Safety Trial

Who this might be right for
Lung Transplant InfectionHeart Transplant InfectionKidney Transplant Infection+2 more
Jordan Feld 40
Testing effectiveness (Phase 2)Study completedNCT00914849
What this trial is testing

Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

Who this might be right for
Hematologic Neoplasms
Washington University School of Medicine 68
Large-scale testing (Phase 3)Study completedNCT00321113
What this trial is testing

Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

Who this might be right for
KIDNEY TRANSPLANTATION
Astellas Pharma Inc 142
Early research (Phase 1)WithdrawnNCT04737161
What this trial is testing

Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress SyndromeCovid19
Stanford University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06134843
What this trial is testing

Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

Who this might be right for
Skin Graft Complications
Hobart W. Harris 12
Not applicableEnded earlyNCT03624192
What this trial is testing

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

Who this might be right for
Skin; Deformity
Avita Medical 3
Testing effectiveness (Phase 2)Study completedNCT02134314
What this trial is testing

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Who this might be right for
End Stage Renal DiseaseKidney FailureDelayed Graft Function+1 more
Cedars-Sinai Medical Center 70
Large-scale testing (Phase 3)Study completedNCT03801707
What this trial is testing

Utilization of Hepatitis C Positive Kidneys in Negative Recipients

Who this might be right for
Kidney TransplantHepatitis CHCV
Ohio State University 54
Testing effectiveness (Phase 2)Study completedNCT03164265
What this trial is testing

DCreg in Living Donor Liver Transplantation

Who this might be right for
Living Donor Liver Transplantation
Angus W. Thomson PhD DSc 16
Testing effectiveness (Phase 2)Study completedNCT01220895
What this trial is testing

Alternate Donor Study of Pre-Emptive Cellular Therapy

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 52
Early research (Phase 1)UnknownNCT03463928
What this trial is testing

A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia

Who this might be right for
B Cell Leukemia
Chinese PLA General Hospital 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05369975
What this trial is testing

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 225
Large-scale testing (Phase 3)Study completedNCT02329457
What this trial is testing

VZV Vaccine for Hematopoietic Stem Cell Transplantation

Who this might be right for
Varicella Zoster Infection
The University of Hong Kong 100
Early research (Phase 1)Study completedNCT00586703
What this trial is testing

Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

Who this might be right for
Lymphoma
David Rizzieri, MD 21
Testing effectiveness (Phase 2)Study completedNCT00570245
What this trial is testing

Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation

Who this might be right for
Lung Transplantation
Mallinckrodt 49
Early research (Phase 1)Active Not RecruitingNCT04248192
What this trial is testing

Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)

Who this might be right for
HIV-Infected Individuals
Catherine Bollard 8
Not applicableActive Not RecruitingNCT04910867
What this trial is testing

APOL1 Genetic Testing Program for Living Donors

Who this might be right for
Chronic Kidney DiseasesApolipoprotein L1Kidney Transplantation
Northwestern University 206
Early research (Phase 1)Ended earlyNCT02295501
What this trial is testing

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Who this might be right for
Acute Ebola Virus Disease
Cerus Corporation 6
Load More Results